-- Bausch + Lomb's (BLCO) Q1 likely saw revenue tailwinds from foreign exchange, continuing trends from Q4, RBC Capital Markets said in a Thursday note.
Broad currency strength, compared with the US dollar, is estimated to have yielded about a $40 million revenue benefit in Q1 and will likely add about $70 million for all of 2026, RBC said. The company's 2026 revenue guidance currently calls for a $30 million FX tailwind, RBC said.
Bausch + Lomb is set to report its Q1 results on April 29 and investors are expected to focus on the company's primary prescription for dry eye disease products, the investment firm added. RBC said investor concerns include Miebo's profitability in 2026 and Xiidra's net pricing improvement.
RBC has an outperform rating on Bausch + Lomb, with a $21 price target.
Price: $15.75, Change: $-0.03, Percent Change: -0.19%